Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Cancer Research UK Partners with Nxera on Next-Stage Trial for HTL0039732

Summary by pharmtech.com
The Phase IIa study will test HTL0039732 in combination with immunotherapy to boost responses in resistant solid tumors and broaden treatment choices.

2 Articles

pharmtech.compharmtech.com
Center

Cancer Research UK Partners with Nxera on Next-Stage Trial for HTL0039732

The Phase IIa study will test HTL0039732 in combination with immunotherapy to boost responses in resistant solid tumors and broaden treatment choices.

Read Full Article
pharmatimes.compharmatimes.com

Nxera and Cancer Research UK begin phase 2a trial of HTL0039732

First patient dosed in study of novel EP4 antagonist for advanced solid tumours

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

pharmatimes.com broke the news in on Wednesday, September 17, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

London, England icon

London, England

News
For You
SearchBlindspotLocal